BioSpace News Archive

Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments, has entered into an agreement to in license a novel topical anti-TNF alpha antibody from Novartis.

January 4, 2019
·
3 min read
Job Trends

P&G Ventures to showcase the Opté™ Precision Skincare System at CES 2019

Startup studio launches first-ever precision at-home skincare device that scans your complexion and immediately corrects hyperpigmentation leaving flawless-looking skin

January 4, 2019
·
3 min read
Business

SCFG Hosts 42nd Annual Summer Fun & Enrichment Camp For Youth Living With Sickle Cell Disease

The Sickle Cell Foundation of Georgia, Inc. is sponsoring Camp New Hope July 21-27, 2019 at one of Georgia’s most historic and respected camp sites, Rock Eagle 4-H Center in Eatonton, Georgia.

January 4, 2019
·
2 min read
Pharm Country

OncLive® Presents State of the Science Summit™ on Breast Cancer

OncLive® will host its latest State of the Science Summit™ on breast cancer updates from recent medical conferences on Monday, Jan. 14, from 5 to 9 p.m. at the Millennium Maxwell House Nashville in Tennessee

January 4, 2019
·
2 min read
Global Bronchitis Drugs Market 2018-2022| Use of Off-Label Drugs for Bronchitis to Boost Growth | Technavio

The global bronchitis drugs market is expected to post a CAGR of close to 4% during the period 2018-2022, according to the latest market research report by Technavio

January 4, 2019
·
4 min read
Pharm Country

InventHelp Inventor Develops Germ Guard (CCT-42711)

“As a man, I do not want to contract anything from a home or public bathroom so I always hold my genitals to keep them away from the rim of the toilet,” said an inventor from Cincinnati, Ohio. “This inspired me to develop a means to protect men from germs and diseases when seated on the toilet.”

January 4, 2019
·
1 min read
Ascension Healthcare plc Business Update And Change of Name from Pro Bono Bio

Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis today provides a business update and announces a Company change of name from Pro Bono Bio.

January 4, 2019
·
12 min read